234 related articles for article (PubMed ID: 21406399)
1. CARMA3 is crucial for EGFR-Induced activation of NF-κB and tumor progression.
Jiang T; Grabiner B; Zhu Y; Jiang C; Li H; You Y; Lang J; Hung MC; Lin X
Cancer Res; 2011 Mar; 71(6):2183-92. PubMed ID: 21406399
[TBL] [Abstract][Full Text] [Related]
2. The CBM Complex Underwrites NF-κB Activation to Promote HER2-Associated Tumor Malignancy.
Pan D; Zhu Y; Zhou Z; Wang T; You H; Jiang C; Lin X
Mol Cancer Res; 2016 Jan; 14(1):93-102. PubMed ID: 26392569
[TBL] [Abstract][Full Text] [Related]
3. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation.
Grabiner BC; Blonska M; Lin PC; You Y; Wang D; Sun J; Darnay BG; Dong C; Lin X
Genes Dev; 2007 Apr; 21(8):984-96. PubMed ID: 17438001
[TBL] [Abstract][Full Text] [Related]
4. CXCL12/SDF-1 alpha activates NF-kappaB and promotes oral cancer invasion through the Carma3/Bcl10/Malt1 complex.
Rehman AO; Wang CY
Int J Oral Sci; 2009 Sep; 1(3):105-18. PubMed ID: 20695076
[TBL] [Abstract][Full Text] [Related]
5. TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression.
Jiang C; Zhu Y; Zhou Z; Gumin J; Bengtsson L; Wu W; Songyang Z; Lang FF; Lin X
Oncogene; 2017 May; 36(20):2813-2823. PubMed ID: 27991920
[TBL] [Abstract][Full Text] [Related]
6. CARMA3: Scaffold Protein Involved in NF-κB Signaling.
Zhang S; Lin X
Front Immunol; 2019; 10():176. PubMed ID: 30814996
[TBL] [Abstract][Full Text] [Related]
7. CARMA3 Is a Host Factor Regulating the Balance of Inflammatory and Antiviral Responses against Viral Infection.
Jiang C; Zhou Z; Quan Y; Zhang S; Wang T; Zhao X; Morrison C; Heise MT; He W; Miller MS; Lin X
Cell Rep; 2016 Mar; 14(10):2389-401. PubMed ID: 26947079
[TBL] [Abstract][Full Text] [Related]
8. CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion.
Du S; Jia L; Zhang Y; Fang L; Zhang X; Fan Y
Tumour Biol; 2014 Jun; 35(6):5965-70. PubMed ID: 24633921
[TBL] [Abstract][Full Text] [Related]
9. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent.
Borthakur A; Bhattacharyya S; Alrefai WA; Tobacman JK; Ramaswamy K; Dudeja PK
Inflamm Bowel Dis; 2010 Apr; 16(4):593-603. PubMed ID: 19714753
[TBL] [Abstract][Full Text] [Related]
11. Linear Ubiquitination Mediates EGFR-Induced NF-κB Pathway and Tumor Development.
Hua F; Hao W; Wang L; Li S
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769306
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
Delekta PC; Apel IJ; Gu S; Siu K; Hattori Y; McAllister-Lucas LM; Lucas PC
J Biol Chem; 2010 Dec; 285(53):41432-42. PubMed ID: 21041303
[TBL] [Abstract][Full Text] [Related]
13. ABINs inhibit EGF receptor-mediated NF-kappaB activation and growth of EGF receptor-overexpressing tumour cells.
Huang L; Verstrepen L; Heyninck K; Wullaert A; Revets H; De Baetselier P; Beyaert R
Oncogene; 2008 Oct; 27(47):6131-40. PubMed ID: 18622428
[TBL] [Abstract][Full Text] [Related]
14. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling.
Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL
J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308
[TBL] [Abstract][Full Text] [Related]
15. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
[TBL] [Abstract][Full Text] [Related]
16. Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9.
Hara H; Ishihara C; Takeuchi A; Xue L; Morris SW; Penninger JM; Yoshida H; Saito T
J Immunol; 2008 Jul; 181(2):918-30. PubMed ID: 18606643
[TBL] [Abstract][Full Text] [Related]
17. The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.
McCully RR; Pomerantz JL
Mol Cell Biol; 2008 Sep; 28(18):5668-86. PubMed ID: 18625728
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.
Biswas DK; Cruz AP; Gansberger E; Pardee AB
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8542-7. PubMed ID: 10900013
[TBL] [Abstract][Full Text] [Related]
19. The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival.
Zhang S; Pan D; Jia XM; Lin X; Zhao X
Protein Cell; 2017 Nov; 8(11):856-860. PubMed ID: 28717989
[No Abstract] [Full Text] [Related]
20. A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.
Li Z; Yang Z; Passaniti A; Lapidus RG; Liu X; Cullen KJ; Dan HC
Oncotarget; 2016 May; 7(22):31892-906. PubMed ID: 26895469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
